Skip to main content
SpringerLink
Log in

Nasal Polyp, Analgesic Intolerance, and Bronchial Hyperreactivity

  • Chapter
  • First Online:
Nasal Polyposis

  • 1409 Accesses

Abstract

The coexistence of bronchial asthma, persistent rhinosinusitis/nasal polyp, and analgesic intolerance is called as Samter’s syndrome or aspirin-induced or analgesic-induced asthma. This condition should be investigated especially if the asthma is severe and/or the polyps are recurrent. There seems to be no ideal curative treatment modality for nasal polyposis. Similar results are reported after medical or surgical polypectomy. Recurrence is possible and frequent with both methods. Aspirin desensitization can be applied as a complementary treatment option. Although some patients improve with this method, long-term results are not yet known.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adamjee J, Suh YJ, Park HS et al (2006) Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J Pathol 209:392–399

    Article  PubMed  CAS  Google Scholar 

  2. Akira S, Kishimoto T (1997) NF-IL6 and NF-kappaB in cytokine regulation. Adv Immunol 65:1–46

    Article  PubMed  CAS  Google Scholar 

  3. Alobid I, Benitez P, Bernal-Sprekelsen M (2005) et al Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 60:452–458

    Article  PubMed  CAS  Google Scholar 

  4. Alobid I, Benitez P, Bernal-Sprekelsen M et al (2005) The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res 14:789–793

    Article  PubMed  Google Scholar 

  5. Bavbek S, Çelik G, Ediger D et al (2000) Severity and associated risk factors in adult asthmatic patients in Turkey. Ann Allergy Asthma Immunol 85:134–139

    Article  PubMed  CAS  Google Scholar 

  6. Bavbek S, Dursun B, Dursun E et al (2007) Safety of meloxicam in aspirin-intolerant patients with asthma and/or nasal polyps: a challenge-proved study. Int Arch Allergy Immunol 142(1):64–69

    Google Scholar 

  7. Berges-Gimeno MP, Simon RA, Stevenson DD (2002) The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89:474–478

    Article  PubMed  Google Scholar 

  8. Bonfils P, Avan P (2004) Non-specific bronchial hyperresponsiveness is a risk factor for steroid insensitivity in nasal polyposis. Acta Otolayngol 124:290–296

    Article  CAS  Google Scholar 

  9. Celiker V, Basgul E, Karakaya G et al (2004) General anesthesia and postoperative pain management in analgesic intolerant patients with/without asthma: is it safe? Allergol Immunopathol 32(2):64–68

    Article  CAS  Google Scholar 

  10. Ergan Arsava B, Karakaya G, Kalyoncu AF (2008) Childhood onset AI: a marker for bronchial asthma in adulthood? Resp Med 102:1011–1014

    Google Scholar 

  11. Gosepath J, Mann WJ (2005) Current concepts in therapy of chronic rhinosinusitis and nasal polyposis. ORL 67: 125–136

    Article  PubMed  Google Scholar 

  12. Gosepath J, Schafer D, Mann WJ (2002) Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using maintenance dose of 100 mg of aspirin a day. Laryngorhinootologie 81:732–738

    Article  PubMed  CAS  Google Scholar 

  13. Hedman J, Kaprio J, Poussa N et al (1999) Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28:717–722

    Article  PubMed  CAS  Google Scholar 

  14. Isik SR, Karakaya G, Celikel S, Demir AU, Kalyoncu AF. Association between asthma, rhinitis and NSAID hypersensitivity in chronic urticaria patients and prevalence rates. Int Arch Allergy Immunol. 2009;150(3):299–306.

    Article  PubMed  CAS  Google Scholar 

  15. Jenkins C, Costello J, Hodge L (2004) Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 328:434–437

    Article  PubMed  CAS  Google Scholar 

  16. Kaldenbach T, Schafer D, Gosepath J et al (1999) Significance of eosinophilic granulocytes in relation to allergy and aspirin intolerance in patients with sinusitis polyposa. Laryngorhinootologie 78:429–243 (in German)

    Google Scholar 

  17. Kalyoncu AF (2000) Aspirin-induced asthma needs a classification. Allergol Immunopathol 28(6):334–335

    CAS  Google Scholar 

  18. Kalyoncu AF, Karakoca Y, Demir AU et al (1996) Prevalence of asthma and allergic diseases in Turkish university students. Allergol Immunopathol 24:152–157

    CAS  Google Scholar 

  19. Kalyoncu AF, Karakaya G, Şahin AA et al (1999) Occurrence of allergic conditions in asthmatics with analgesic intolerance. Allergy 54:428–435

    Article  PubMed  CAS  Google Scholar 

  20. Kalyoncu AF, Karakaya G, Yılmaz E et al (2003) Analgesic intolerance with or without bronchial asthma: is there a marker? J Investig Allergol Clin Immunol 13(3):162–169

    PubMed  CAS  Google Scholar 

  21. Kalyoncu AF, Karakaya G, Bozkurt B et al (2005) A new method of oral drug provocation testing for determining safe alternatives for patients with non-steroidal anti-inflammatory drug intolerance: the triple test. Int Arch Allergy Immunol 38(4):319–323

    Article  Google Scholar 

  22. Karakaya G, Demir AU, Kalyoncu AF (2000) From analgesic intolerance to analgesic induced asthma: are there some determinants? Allergol Immunopathol 28(4):229–237

    CAS  Google Scholar 

  23. Karakaya G, Kalyoncu AF (2000) Safety of nimesulide, meloxicam and rofecoxib as alternative analgesics. Allergol Immunopathol 28(6):319–321

    CAS  Google Scholar 

  24. Killen JWW, Wilson JA, Gibson GJ (2003) Subclinical aspirin sensitivity in subjects with nasal polyposis. Clin Otolayngol 28:539–544

    Article  CAS  Google Scholar 

  25. Kowalski M (2000) Rhinosinusitis and nasal polyposis in aspirin sensitive and tolerant patients: are they different? Thorax 55(Suppl 2):84–86

    Article  Google Scholar 

  26. Kowalski M, Pawliczak R, Wozniak J et al (2000) Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 161:391–398

    PubMed  CAS  Google Scholar 

  27. Kowalski ML, Grzegorczyk J, Pawliczak R et al (2002) Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity. Allergy 57:493–500

    Article  PubMed  CAS  Google Scholar 

  28. Kowalski ML, Ptasinka A, Jedrzejczak M et al (2005) Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPI Test). Allergy 60:1139–1145

    Article  PubMed  CAS  Google Scholar 

  29. Lamblin C, Brichet A, Perez T et al (2000) Long-term follow-up of pulmonary function in patients with nasal polyposis. Am J Respir Crit Care Med 161:406–413

    PubMed  CAS  Google Scholar 

  30. Lebel B, Messaad D, KvedarieneV et al (2001) Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate reactions. Allergy 56:688–692

    Google Scholar 

  31. Marquette CH, Saulnier F, Leroy O et al (1992) Long-term prognosis for near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanichal ventilation for near-fatal attack of asthma. Am Rev Respir Dis 146:76–81

    PubMed  CAS  Google Scholar 

  32. Mastalerz L, Sanak M, Gawlewicz-Mroczka A et al (2008) Prostaglandin E2 systemic production in asthma patients with and without aspirin hypersensitivity. Thorax 63(1):27–34

    Article  PubMed  CAS  Google Scholar 

  33. May A, Weber A, GAll H et al (1999) Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy 29:1402–1411

    Article  PubMed  CAS  Google Scholar 

  34. Min JW, Jang AS, Park SM et al (2005) Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients. Chest 128:3127–3132

    Article  PubMed  CAS  Google Scholar 

  35. Molnar-Gabor E, Endreffy E, Rozsasi A (2000) Differences in HLA genes is considered as one of the reasons for the high prevalence of the polyposis in AIA, HLA-DRB1, DQA1, and DQB1 genotypes in patients with nasal polyposis. Laryngoscope 110:422–425

    Article  PubMed  CAS  Google Scholar 

  36. Niżankowska-Mogilnicka E, Bochenek G, Mastalerz L et al (2007) EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62(10):1111–1118

    Article  PubMed  Google Scholar 

  37. Park HS, Nahm DH, Park K et al (1988) Immunohistochemical characterization of cellular infiltrate in nasal polyps from aspirin-sensitive asthmatic patients. Ann Allergy Asthma Immunol 81:219–224

    Article  Google Scholar 

  38. Pawankar R (2003) Nasal polyposis: an update. Curr Opin Allergy Clin Immunol 3:1–6

    Article  PubMed  CAS  Google Scholar 

  39. Peat JK, Salome CM, Woolcock AJ (1992) Factors associated with bronchial hyperresponsiveness in Australian adults and children. Eur Respir J 5:921–929

    PubMed  CAS  Google Scholar 

  40. Picado C (2002) Aspirin intolerance and nasal polyposis. Curr Allergy Asthma Rep 2:488–493

    Article  PubMed  Google Scholar 

  41. Picado C, Fernandez-Morata F, Juan M et al (1999) Cycloxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 160:291–296

    PubMed  CAS  Google Scholar 

  42. Picado C, Bioque G, Roca-Ferrer J et al (2003) Nuclear factor-kappa B activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy 58:122–126

    Article  PubMed  CAS  Google Scholar 

  43. Pierzchalska M, Mastalerz L, Sanak M et al (2000) A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma. Clin Exp Allergy 30:1785–1791

    Article  PubMed  CAS  Google Scholar 

  44. Pierzchalska M, Zsabo Z, Sanak M et al (2003) Deficient prostoglandin E2 production by bronchial fibroblasts of asthmatic patients with special reference to aspirin-induced asthma. J Allergy Clin Immunol 111:1041–1048

    Article  PubMed  CAS  Google Scholar 

  45. Pujols L, Mullol J, Alobid I et al (2004) Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol 114:814–819

    Article  PubMed  CAS  Google Scholar 

  46. Rosado A, Vives R, Gonzales R et al (2003) Can NSAIDs intolerance disappear? A study of three cases. Allergy 58:689–690

    Article  PubMed  CAS  Google Scholar 

  47. Sampson AP, Cowburn AS, Sladek K et al (1997) Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int Arch Allergy Immunol 113:355–357

    Article  PubMed  CAS  Google Scholar 

  48. Sanz ML, Gamboa P, de Weck AL (2005) A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 136:58–72

    Article  PubMed  CAS  Google Scholar 

  49. Schafer D, Schmid M, Göde UC et al (1999) Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J 13:638–646

    Article  PubMed  CAS  Google Scholar 

  50. Schiavino D, Nucera E, Milani A et al (2000) The aspirin disease. Thorax 55(suppl 2):66–69

    Article  Google Scholar 

  51. Schmid M, Göde U, Schafer D et al (1999) Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics. Acta Otolaryngol (Stockholm) 119:277–280

    Article  CAS  Google Scholar 

  52. Stevenson DD, Simon RA (2006) Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 118:801–804

    Article  PubMed  Google Scholar 

  53. Stevenson DD, Szczeklik A (2006) Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118:773–786

    Article  PubMed  CAS  Google Scholar 

  54. Suh YJ, Yoon SH, Sampson AP et al (2004) Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma. Clin Exp Allergy 34:1270–1275

    Article  PubMed  CAS  Google Scholar 

  55. Szczeklik A, Nizankowska E (2000) Clinical features and diagnosis of aspirin induced asthma. Thorax 55(suppl 2):42–44

    Article  Google Scholar 

  56. Szczeklik A, Nizankowska E, Duplaga M; on behalf of the AIANE investigators (2000) Natural history of aspirin-induced asthma. Eur Respir J 16:432–436

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest Diseases Adult Allergy Unit, Hacettepe University School of Medicine, 06100, Sihhiye, Ankara, Turkey

    Gül Karakaya & A. Fuat Kalyoncu

Authors
  1. Gül Karakaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Fuat Kalyoncu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Fuat Kalyoncu .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Dept. of Otorhinolaryngology, Hacettepe University, Ankara, 06100, Turkey

    T. Metin Önerci

  2. School of Medicine, Dept. Otolaryngology, University of Pittsburgh, Locust Street 1400, Pittsburgh, 15219, USA

    Berrylin J. Ferguson

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Karakaya, G., Kalyoncu, A.F. (2010). Nasal Polyp, Analgesic Intolerance, and Bronchial Hyperreactivity. In: Önerci, T., Ferguson, B. (eds) Nasal Polyposis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11412-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11412-0_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11411-3

  • Online ISBN: 978-3-642-11412-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation